Report Detail

Request for Sample of this report

Pharma & Healthcare Global Osteoarthritis Pain Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3117186
    • |
  • 13 March, 2019
    • |
  • Global
    • |
  • 116 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers:

Painkillers only: Only a simple analgesic effect, but no anti-inflammatory function, such as acetaminophen, tramadol. Acetaminophen side effects, but the analgesic effect is relatively weak, mainly for mild to moderate pain; tramadol analgesic effect is strong, but also side effects are larger, mainly gastrointestinal side effects such as nausea, vomiting and so on.

NSAIDs: With both anti-inflammatory and analgesic effect, suitable for inflammatory pain, for the acute phase of osteoarthritis, joint swelling of the patients to relieve symptoms better. These drugs may lead to nausea, vomiting and other gastrointestinal discomfort, but also increase the risk of gastrointestinal bleeding, so patients with gastro duodenal ulcer in the application of these drugs should consult a digestive physician, plus gastric mucosal protection Drugs or antacid drugs.

Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint.

Scope of the Report:
Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement.
The USA osteoarthritis pain drugs market is very concerted market; the revenue of eleven manufacturers accounts about 88% of the total revenue in 2016. The high-end products mainly come from USA and Europe.
The leading manufactures mainly are Johnson & Johnson, Pfizer and GlaxoSmithKline. Johnson & Johnson is the largest manufacturer; its revenue of USA market exceeds 27% in 2016. The next is Pfizer and GlaxoSmithKline.
The worldwide market for Osteoarthritis Pain Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Osteoarthritis Pain Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Johnson & Johnson
Pfizer
GlaxoSmithKline
Mylan
Lilly
Sanofi
Abbott Laboratories
Bayer
Almatica Pharma
TEVA
Iroko Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral
Injection
External

Market Segment by Applications, can be divided into
Medical Care
Personal Care

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Osteoarthritis Pain Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Osteoarthritis Pain Drugs, with price, sales, revenue and global market share of Osteoarthritis Pain Drugs in 2017 and 2018.
Chapter 3, the Osteoarthritis Pain Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Osteoarthritis Pain Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Osteoarthritis Pain Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Osteoarthritis Pain Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Osteoarthritis Pain Drugs Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Oral
      • 1.2.2 Injection
      • 1.2.3 External
    • 1.3 Market Analysis by Applications
      • 1.3.1 Medical Care
      • 1.3.2 Personal Care
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Johnson & Johnson
      • 2.1.1 Business Overview
      • 2.1.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Pfizer
      • 2.2.1 Business Overview
      • 2.2.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 GlaxoSmithKline
      • 2.3.1 Business Overview
      • 2.3.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Mylan
      • 2.4.1 Business Overview
      • 2.4.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Lilly
      • 2.5.1 Business Overview
      • 2.5.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Sanofi
      • 2.6.1 Business Overview
      • 2.6.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Abbott Laboratories
      • 2.7.1 Business Overview
      • 2.7.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Bayer
      • 2.8.1 Business Overview
      • 2.8.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Almatica Pharma
      • 2.9.1 Business Overview
      • 2.9.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 TEVA
      • 2.10.1 Business Overview
      • 2.10.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Iroko Pharmaceuticals
      • 2.11.1 Business Overview
      • 2.11.2 Osteoarthritis Pain Drugs Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Osteoarthritis Pain Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Osteoarthritis Pain Drugs Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Osteoarthritis Pain Drugs Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Osteoarthritis Pain Drugs Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Osteoarthritis Pain Drugs Market Analysis by Regions

    • 4.1 Global Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Osteoarthritis Pain Drugs Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 4.3 Europe Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 4.5 South America Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)

    5 North America Osteoarthritis Pain Drugs by Country

    • 5.1 North America Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Country
      • 5.1.1 North America Osteoarthritis Pain Drugs Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Osteoarthritis Pain Drugs Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 5.3 Canada Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)

    6 Europe Osteoarthritis Pain Drugs by Country

    • 6.1 Europe Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Osteoarthritis Pain Drugs Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Osteoarthritis Pain Drugs Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 6.3 UK Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 6.4 France Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 6.5 Russia Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 6.6 Italy Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Osteoarthritis Pain Drugs by Country

    • 7.1 Asia-Pacific Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Osteoarthritis Pain Drugs Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Osteoarthritis Pain Drugs Revenue and Market Share by Country (2014-2019)
    • 7.2 China Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 7.3 Japan Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 7.4 Korea Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 7.5 India Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)

    8 South America Osteoarthritis Pain Drugs by Country

    • 8.1 South America Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Country
      • 8.1.1 South America Osteoarthritis Pain Drugs Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Osteoarthritis Pain Drugs Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Osteoarthritis Pain Drugs by Countries

    • 9.1 Middle East and Africa Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Osteoarthritis Pain Drugs Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Osteoarthritis Pain Drugs Sales and Growth Rate (2014-2019)

    10 Global Osteoarthritis Pain Drugs Market Segment by Type

    • 10.1 Global Osteoarthritis Pain Drugs Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Osteoarthritis Pain Drugs Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Oral Sales Growth and Price
      • 10.2.1 Global Oral Sales Growth (2014-2019)
      • 10.2.2 Global Oral Price (2014-2019)
    • 10.3 Injection Sales Growth and Price
      • 10.3.1 Global Injection Sales Growth (2014-2019)
      • 10.3.2 Global Injection Price (2014-2019)
    • 10.4 External Sales Growth and Price
      • 10.4.1 Global External Sales Growth (2014-2019)
      • 10.4.2 Global External Price (2014-2019)

    11 Global Osteoarthritis Pain Drugs Market Segment by Application

    • 11.1 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2014-2019)
    • 11.2 Medical Care Sales Growth (2014-2019)
    • 11.3 Personal Care Sales Growth (2014-2019)

    12 Osteoarthritis Pain Drugs Market Forecast (2019-2024)

    • 12.1 Global Osteoarthritis Pain Drugs Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Osteoarthritis Pain Drugs Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Osteoarthritis Pain Drugs Market Forecast (2019-2024)
      • 12.2.2 Europe Osteoarthritis Pain Drugs Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Osteoarthritis Pain Drugs Market Forecast (2019-2024)
      • 12.2.4 South America Osteoarthritis Pain Drugs Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Osteoarthritis Pain Drugs Market Forecast (2019-2024)
    • 12.3 Osteoarthritis Pain Drugs Market Forecast by Type (2019-2024)
      • 12.3.1 Global Osteoarthritis Pain Drugs Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Osteoarthritis Pain Drugs Market Share Forecast by Type (2019-2024)
    • 12.4 Osteoarthritis Pain Drugs Market Forecast by Application (2019-2024)
      • 12.4.1 Global Osteoarthritis Pain Drugs Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Osteoarthritis Pain Drugs Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Osteoarthritis Pain Drugs . Industry analysis & Market Report on Osteoarthritis Pain Drugs is a syndicated market report, published as Global Osteoarthritis Pain Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Osteoarthritis Pain Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,752.68
      		4,129.02
      		5,505.36
      		3,208.56
      		4,812.84
      		6,417.12
      		540,444.00
      		810,666.00
      		1,080,888.00
      		290,580.00
      		435,870.00
      		581,160.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo